EgyptEgypt's Egyptian Drug Authority mandates a licensed local legal representative for every foreign medical devices manufacturer seeking registration. Taevas Global acts as your authorised in-country representative, handling EDA submissions, correspondence,
Our Legal Representation service is built on six interconnected pillars that cover every dimension of regulatory compliance, market access, and ongoing post-market obligations in Egypt.
We serve as your official legal representative with the Egyptian Drug Authority, submitting and tracking all device registration dossiers under the Medical Devices Directorate. Our team ensures technical files meet EDA formatting, classification, and documentation requirements from day one. We monitor application status and respond to EDA queries on your behalf, preventing delays caused by incomplete or non-compliant submissions.
Our four-stage engagement model takes you from initial scoping through full EDA registration and commercial readiness, with transparent milestones at every step.
We conduct a structured intake session to understand your device portfolio, existing certifications, target product classes, and commercial timeline. Our regulatory team performs a preliminary gap analysis comparing your technical files against EDA registration requirements. You receive a written scoping report identifying documentation gaps, estimated timelines, and a fixed-fee engagement proposal.
The scoping report covers device classification under the Egyptian risk-based framework, an inventory of required technical file components, a regulatory pathway recommendation (new registration vs. equivalence route), estimated EDA fees, and a project plan with owner-assigned milestones. This deliverable is provided within five business days of the kick-off call and forms the contractual basis for the engagement.
Egypt imports more than 60 percent of its medical devices, making it one of the most import-reliant markets in the Middle East and Africa region. Local manufacturing is concentrated in consumables and basic equipment, while advanced diagnostic, imaging, and surgical devices are predominantly sourced from Europe, the United States, and China. This dependency creates a sustained and growing opportunity for foreign manufacturers with the right regulatory access.
The Egyptian Drug Authority, established under Law No. 151 of 2019, has been actively modernising the medical device registration framework to align with international standards including IMDRF and GHTF guidelines. New electronic submission portals and updated registration guidelines have been introduced since 2021, reducing paper-based processing and improving transparency. Manufacturers who engage early with the new digital submission system gain a meaningful speed advantage over competitors still using legacy processes.
The Egyptian public sector, led by the Ministry of Health and Population and the Health Insurance Authority, accounts for the majority of medical device procurement through centralised tender processes. Egypt's Universal Health Insurance Law, enacted in 2018 and being implemented in phases, is driving significant expansion of healthcare infrastructure and device procurement budgets. Foreign manufacturers must be EDA-registered and meet local tender qualification criteria to access this dominant procurement channel.
Egypt's private hospital and clinic sector has expanded rapidly, with major healthcare groups investing in advanced diagnostic imaging, minimally invasive surgery, and point-of-care diagnostics. Cities including Cairo, Alexandria, and Giza host a growing concentration of internationally accredited private hospitals that source devices directly from international manufacturers or through authorised distributors. This segment offers faster procurement cycles and premium pricing compared to the public tender pathway.
Every Legal Representation engagement with Taevas Global includes eight core deliverables designed to take your medical device from foreign manufacturer to EDA-registered, commercially active product in Egypt.
A written assessment of your technical files against EDA registration requirements, identifying missing documents, labelling gaps, and recommended corrective actions before submission.
Complete preparation of the EDA application package including technical documentation, Arabic labelling, free sale certificates, and all supporting declarations required for your device class.
End-to-end management of apostille or consular legalisation for all foreign documents, including coordination with Egyptian embassies and certified translation services.
Official appointment documentation naming Taevas Global as your authorised legal representative in Egypt, executed in the format required by EDA and authenticated as necessary.
Preparation and submission of your import licence application to EDA following registration approval, including all supporting documentation required for each product line.
Professional drafting and submission of all responses to EDA technical queries during the review period, with escalation protocols to minimise delays and prevent application lapsing.
A tailored PMS plan and adverse event reporting procedure aligned with EDA post-market requirements, including templates for vigilance reporting and field safety corrective actions.
A structured handover session for your commercial and distribution teams covering registration certificate management, renewal timelines, distributor obligations, and ongoing compliance requirements.
You have CE marking or FDA clearance and are ready to expand into Egypt, but you have no local entity, no EDA relationships, and no in-house knowledge of Egyptian regulatory requirements. EDA mandates a licensed local legal representative before any registration can proceed, making this the critical first step. Taevas Global provides the mandatory local presence and the regulatory expertise to move your dossier through EDA efficiently.
Whether you are entering Egypt for the first time or rescuing a stalled EDA application, Taevas Global provides the local regulatory authority, the documentation expertise, and the stakeholder relationships to get your medical devices registered and commercially active in Egypt.